Navigation Links
I dati presentati a Global Addiction generano preoccupazione relativamente all'efficacia delle attuali misure per il trattamento della dipendenza da oppioidi
Date:5/7/2013

le di alcun genere, nonostante vi siano prove del fatto che tale sostegno è in grado di migliorare gli esiti del trattamento[1]
  • Esiste una notevole differenza nella percezione delle diverse opzioni di trattamento, anche se la scelta informata del paziente è considerata critica per l'accesso dei pazienti alla terapia e per i relativi esiti[1]
  • Secondo le direttive della OMS del 2008, è stato dimostrato che la normalizzazione della dipendenza con una terapia presso un ente di assistenza sanitaria di base ha un impatto positivo sugli esiti del trattamento. In Francia, i medici che hanno erogato la terapia erano quasi esclusivamente medici di base (93%) e i dati hanno dimostrato che la Francia è stata particolarmente associata al tasso più basso di overdose (2%) e al tasso più alto di occupazione dei pazienti (59%).[1]

  • "Questi risultati evidenziano che, sebbene negli ultimi anni siano stati fatti notevoli progressi nel passaggio da un modello di limitazione del danno a una piattaforma di cura per la guarigione, gli attuali sistemi di terapia non sono ancora in grado di conseguire esiti ottimali per la maggior parte dei pazienti", commenta Icro Maremmani, co-Presidente di Global Addiction e Docente di Medicina delle Farmacotossicodipendenze all'Università di Pisa, Italia. "L'incontro di menti tra i principali legislatori e specialisti medici europei in occasione di Global Addiction segna un ulteriore progresso nel percorso verso la normalizzazione delle dipendenze e il conseguimento della guarigione per i pazienti. L'incontro è una piattaforma di discussione sui contesti per lo sviluppo di valide stime dei costi della dipendenza da oppioidi non trattata e per la creazione di un approccio innovativo nella comparazione dei risultati ottenuti con la gestione degli oppioidi, inclusa l'acquisizione dei risultati relativi a quattro aspetti: mo
    '/>"/>

    SOURCE Global Addiction
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related biology technology :

    1. Sangamo BioSciences Announces Presentation At The Needham Healthcare Conference
    2. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE 12TH ANNUAL NEEDHAM HEALTHCARE CONFERENCE
    3. Sangamo BioSciences Announces Presentation At Regen Med Investor Day
    4. Rosetta Genomics Announces Poster Presentations at AACR Annual Meeting 2013
    5. Senomyx To Webcast Corporate Presentation At The 25th Annual ROTH Conference
    6. Ion Semiconductor Sequencing Data Presentations at AGBT Demonstrate More than >1,000-fold Throughput Scaling in First Two Years on the Market
    7. Store-A-Tooth™ Stem Cell Banking Announces Appointment of Dedicated Sales Representative in New England
    8. Sigma-Aldrich Corporation Declares Increased Quarterly Dividend; Announces Live Webcasts Of Presentations At Two Upcoming Conferences
    9. Keryx Biopharmaceuticals to Present at the 15th Annual BIO CEO & Investor Conference Presentation Scheduled for Monday, February 11th at 2:30 PM ET
    10. Probiotic Action Representative Fernando Perez Shares Tips for Parents with Teens Suffering from Acne and Depression
    11. Store-A-Tooth™ Dental Stem Cell Banking Announces Appointment of Dedicated Representative in South Florida
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:2/27/2015)... Feb. 27, 2015  Steep Hill, the industry leader ... internationally, intends to open a full service medical cannabis ... , bringing advanced scientific tools and methodology to ... Steep Hill is currently the only laboratory licensed by ... and contaminant testing in order to meet the recently ...
    (Date:2/26/2015)... N.J. , Feb. 26, 2015 On ... and its affiliated companies, Wilentz, Goldman & Spitzer, ... trade secrets lawsuit against Genewiz Inc. in excess of ... and utilized GenScript,s trade secrets, and that it improperly ... entered an order denying motions for judgment notwithstanding the ...
    (Date:2/26/2015)... LEXINGTON, Mass., Feb. 26, 2015   Synageva ... a biopharmaceutical company developing therapeutic products for rare ... and provided 2015 goals, other key objectives, and ... conference call today at 4:30 p.m. EST to ... business update.  To participate in today,s call by ...
    (Date:2/26/2015)... , Feb. 26, 2015 DuPont Executive Vice ... driven by key research advancements and product launches across ... Bank of America Merrill Lynch 2015 Global Agriculture Conference. ... of building grain supplies the last two years, long-term ... the pace of the last decade, when demand for ...
    Breaking Biology Technology:Steep Hill First to Receive Provisional Approval to Establish Laboratory Services for Cannabis Testing in State of New Mexico 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3Synageva BioPharma Reports 2014 Full Year Financial Results 2Synageva BioPharma Reports 2014 Full Year Financial Results 3Synageva BioPharma Reports 2014 Full Year Financial Results 4Synageva BioPharma Reports 2014 Full Year Financial Results 5Synageva BioPharma Reports 2014 Full Year Financial Results 6Synageva BioPharma Reports 2014 Full Year Financial Results 7Synageva BioPharma Reports 2014 Full Year Financial Results 8Synageva BioPharma Reports 2014 Full Year Financial Results 9DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 2DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 3DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 4DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 5
    ... Icahn confirmed today that,entities affiliated with him have given ... persons at Biogen,s forthcoming 2008 Annual,Meeting of Stockholders to ... board of twelve directors, and there are four directorships,up ... "We are taking this action because we believe,that Biogen,s ...
    ... The VenaFlux(TM) Platform Accurately Mimics a Human ... Cellix Ltd., an international,provider of microfluidic systems ... its worldwide launch of its VenaFlux(TM),Platform. The ... based assay system, measures cell adhesion to,antibody-coated ...
    ... Alexion,Pharmaceuticals, Inc. (Nasdaq: ALXN ), today announced that ... cast on Thursday, February 14,2008, at 10:00 a.m. Eastern ... results for the fourth quarter and full year ended ... 6:30 a.m.,ET on Thursday, February 14, 2008., To ...
    Cached Biology Technology:Icahn Confirms Intention to Nominate Three Directors at Biogen 2Icahn Confirms Intention to Nominate Three Directors at Biogen 3Cellix Ltd. Launches the First Semi-Automated, High Throughput Cell-Adhesion Assay Platform 2
    (Date:2/23/2015)... 23, 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile commerce ... 62114357 for DISTRIBUTED VOICE DIRECTED PAYMENT METHOD ... a new groundbreaking payment method. Payment accounts may be ... only be accessed if both the speech (the word ...
    (Date:2/12/2015)... OXFORD, Conn. , Feb. 12, 2015 ... ("NXT-ID" or the "Company"), a biometric authentication company focused ... it has filed provisional patent 62/113114 for ... MULTIPLE DEVICES. The patent further establishes NXT-ID,s ... to its intellectual property portfolio the ability for multiple ...
    (Date:2/5/2015)... 5, 2015  Marken is starting its 35 th ... launched a new marketing campaign to solidify its place ... new campaign focuses on First as a ... The first headline in the series, ... with its client,s priorities. Marken recognizes the need to ...
    Breaking Biology News(10 mins):NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3Marken Launches New Patient-Centric Campaign 2
    ... Columbine flowers are recognizable by the long, trailing nectar ... tempting the taste buds of their insect pollinators. ... Santa Barbara (UCSB) helps to explain how columbines have ... flowers apparently tailored to the length of their pollinators, ...
    ... partnership with the Office of Naval Research (ONR), Marines ... disposal system that can reduce a standard 50-gallon bag ... Called the Micro Auto Gasification System (MAGS), the ... Forces, Pacific (MARFORPAC) as a possible solution to help ...
    ... today demonstrates the brain,s remarkable capacity to repair itself. ... limit damage after blood and oxygen deprivation and blood ... Neuroscience,s annual meeting and the world,s largest source of ... is the number one cause of long-term disability and ...
    Cached Biology News:Dramatic diversity of columbine flowers explained by a simple change in cell shape 2Dramatic diversity of columbine flowers explained by a simple change in cell shape 3Marines test new energy-efficient weapon in the war on trash 2Brain, repair thyself: Studies highlight brain's resiliency to damage 2
    Human SCP3 Affinity Purified Polyclonal Ab Keywords: Spermatogenesis, meiosis Protein Family: Cell Cycle...
    ... NAP-10 Columns, 50. For rapid and ... 10-mers) in less than 15 minutes by ... in distilled water containing 0.15% Kathon CG/ICP ... volume: 0.5 ml (NAP-5), 1 ml ...
    Homo sapiens alcohol dehydrogenase 5 (class III), chi polypeptide (ADH5), mRNA....
    Human Serpin A3 MAb (Clone 213907)...
    Biology Products: